Why the study?
Severe hypertriglyceridemia presenting with DKA has been reported in few cases, predominantly in type-1 diabetes, and the use of plasmapheresis for severe hypertriglyceridemia has not been well studied.
Does plasmapheresis improve severe hypertriglyceridemia in a patient with type-2 diabetes mellitus and diabetic ketoacidosis?
Does plasmapheresis improve severe hypertriglyceridemia in a patient with type-2 diabetes mellitus and diabetic ketoacidosis?
Plasmapheresis can be an effective and rapid treatment for severe hypertriglyceridemia presenting as a complication of uncontrolled type-2 diabetes mellitus with diabetic ketoacidosis.
May support lipid screening and selective plasmapheresis in similar DKA; leaves open broader use pending trials.
INTRODUCTION: Severe hypertriglyceridemia (HTG) is a rare complication of insulin resistance. Its presentation with diabetic ketoacidosis (DKA) has been reported in a few cases, where most patients have type-1 diabetes mellitus (DM). Our case represents a unique presentation of DKA associated with severe HTG above 10,000 mg/dL in an adult with type-2 DM. PATIENT CONCERNS AND DIAGNOSIS: Case Report: A 51-year-old man with no prior illnesses presented to the emergency department with abdominal pain and nausea. He was found to have DKA with a blood glucose level of 337 mg/dL, pH of 7.17, beta-hydroxybutyrate of 7.93 mmol/L, and anion gap of 20 mmol/L. His triglyceride levels were >10,000 mg/dL. His serum was found to be lipemic. Computerized tomography scan of the abdomen demonstrated mild acute pancreatitis. Negative GAD65 antibodies supported the diagnosis of type-2 DM. INTERVENTIONS AND OUTCOMES: Endocrinology was consulted and one cycle of albumin-bound plasmapheresis was administered. This therapy significantly improved his HTG. DKA gradually resolved with insulin therapy as well. He was discharged home with endocrinology follow-up. CONCLUSION: This unique case highlights an uncommon but critical consequence of uncontrolled DM. It brings forth the possibility of severe HTG presenting as a complication of uncontrolled type-2 DM. Severe HTG commonly presents with acute pancreatitis, which can be debilitating if not managed promptly. Most patients with this presentation are managed with insulin infusion. The use of plasmapheresis for management of severe HTG has not been well studied. Our case supports the use of plasmapheresis as an effective and rapid treatment for severe HTG.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: